For Immediate Release
The Inventor of MR Scanning
An ISO 9001 Company
|Contact: Daniel Culver||110 Marcus Drive|
|Director of Communications||Melville, NY 11747-4292|
|Web site: www.fonar.com||Phone: (631) 694-2929|
|Email: investor @ fonar. com||Fax: (631) 390-1709|
MELVILLE, NEW YORK, March 31, 2021 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, announced today that it has acquired a Stand-Up® MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C.
Tim Damadian, president and CEO of FONAR Corporation, said, “We’re very excited about this Yonkers location. Physicians have been referring their patients to the previous practice at this location for several years. Our goal is to make the transition for both patients and referring doctors as smooth as possible. We now manage two locations in Yonkers. Since they are across town from one another, the additional location very nicely expands and strengthens our presence in Westchester County. By providing the marketing techniques and the quality of service to patients and referring physicians that have made other HMCA-managed facilities successful, we expect not only to preserve the existing level of business, but to substantially increase it.”
This latest acquisition brings the total number of HMCA-managed MRI scanners to 39: Twenty-five (25) in New York and fourteen (14) in Florida.
FONAR, the Inventor of MR Scanning™, located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world’s first commercial MRI in 1980, and went public in 1981. FONAR’s signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ Imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often detects patient problems that other MRI scanners cannot because they are lie-down, ”weightless-only” scanners. The patient-friendly UPRIGHT® MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer states, “If the patient is claustrophobic in this scanner, they’ll be claustrophobic in my parking lot.” Approximately 85% of patients are scanned sitting while watching TV.
FONAR has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body’s neurologic system has been made possible first by FONAR’s introduction of the MRI and now by this latest works-in-progress method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.
FONAR’s primary source of income and growth is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA) www.hmca.com.
FONAR’s substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring the Upright cerebral hydraulics of the cerebrospinal fluid (CSF) of the central nervous system. FONAR’s UPRIGHT® Multi-Position™ MRI is the only scanner licensed under these patents.
UPRIGHT® and STAND-UP® are registered trademarks. The Inventor of MR Scanning™, CSP™, Multi-Position™, UPRIGHT RADIOLOGY™, The Proof is in the Picture™, pMRI™, CSF Videography™, Dynamic™, are trademarks of FONAR Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.